 | • レポートコード：MRC2Q12-19196 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、113ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医薬品＆医療 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、持続型成長ホルモン（LAGH）のグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 持続型成長ホルモン（LAGH）のアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 持続型成長ホルモン（LAGH）の中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 持続型成長ホルモン（LAGH）のヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までの持続型成長ホルモン（LAGH）の生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別の持続型成長ホルモン（LAGH）の売上および2028年までの予測に焦点を当てています。 持続型成長ホルモン（LAGH）のグローバル主要企業には、GeneScience Pharmaceuticals、Pfizer、Novo Nordisk、Eli Lilly、Merck Serono、F. Hoffmann-La Roche、Ferring Pharmaceuticals、Ipsen、LG Life Sciences、Sandoz International、Anhui Anke Biotechnologyなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 持続型成長ホルモン（LAGH）市場は、タイプとアプリケーションによって区分されます。世界の持続型成長ホルモン（LAGH）市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 粉体、溶媒 【アプリケーション別セグメント】 成長ホルモン欠乏症（GHD）、ターナー症候群、慢性腎不全、Prader Willi症候群、Small for Gestational Age（SGA）、SHOX欠乏症、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 持続型成長ホルモン（LAGH）製品概要 - タイプ別市場（粉体、溶媒） - アプリケーション別市場（成長ホルモン欠乏症（GHD）、ターナー症候群、慢性腎不全、Prader Willi症候群、Small for Gestational Age（SGA）、SHOX欠乏症、その他） - 調査の目的 ・エグゼクティブサマリー - 世界の持続型成長ホルモン（LAGH）販売量予測2017-2028 - 世界の持続型成長ホルモン（LAGH）売上予測2017-2028 - 持続型成長ホルモン（LAGH）の地域別販売量 - 持続型成長ホルモン（LAGH）の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別持続型成長ホルモン（LAGH）販売量 - 主要メーカー別持続型成長ホルモン（LAGH）売上 - 主要メーカー別持続型成長ホルモン（LAGH）価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（粉体、溶媒） - 持続型成長ホルモン（LAGH）のタイプ別販売量 - 持続型成長ホルモン（LAGH）のタイプ別売上 - 持続型成長ホルモン（LAGH）のタイプ別価格 ・アプリケーション別市場規模（成長ホルモン欠乏症（GHD）、ターナー症候群、慢性腎不全、Prader Willi症候群、Small for Gestational Age（SGA）、SHOX欠乏症、その他） - 持続型成長ホルモン（LAGH）のアプリケーション別販売量 - 持続型成長ホルモン（LAGH）のアプリケーション別売上 - 持続型成長ホルモン（LAGH）のアプリケーション別価格 ・北米市場 - 北米の持続型成長ホルモン（LAGH）市場規模（タイプ別、アプリケーション別） - 主要国別の持続型成長ホルモン（LAGH）市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの持続型成長ホルモン（LAGH）市場規模（タイプ別、アプリケーション別） - 主要国別の持続型成長ホルモン（LAGH）市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の持続型成長ホルモン（LAGH）市場規模（タイプ別、アプリケーション別） - 主要国別の持続型成長ホルモン（LAGH）市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の持続型成長ホルモン（LAGH）市場規模（タイプ別、アプリケーション別） - 主要国別の持続型成長ホルモン（LAGH）市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの持続型成長ホルモン（LAGH）市場規模（タイプ別、アプリケーション別） - 主要国別の持続型成長ホルモン（LAGH）市場規模（トルコ、サウジアラビア） ・企業情報 GeneScience Pharmaceuticals、Pfizer、Novo Nordisk、Eli Lilly、Merck Serono、F. Hoffmann-La Roche、Ferring Pharmaceuticals、Ipsen、LG Life Sciences、Sandoz International、Anhui Anke Biotechnology ・産業チェーン及び販売チャネル分析 - 持続型成長ホルモン（LAGH）の産業チェーン分析 - 持続型成長ホルモン（LAGH）の原材料 - 持続型成長ホルモン（LAGH）の生産プロセス - 持続型成長ホルモン（LAGH）の販売及びマーケティング - 持続型成長ホルモン（LAGH）の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 持続型成長ホルモン（LAGH）の産業動向 - 持続型成長ホルモン（LAGH）のマーケットドライバー - 持続型成長ホルモン（LAGH）の課題 - 持続型成長ホルモン（LAGH）の阻害要因 ・主な調査結果 |
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Long-Acting Growth Hormone(LAGH) is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Long-Acting Growth Hormone(LAGH) is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Long-Acting Growth Hormone(LAGH) is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key manufacturers of Long-Acting Growth Hormone(LAGH) include GeneScience Pharmaceuticals, Pfizer, Novo Nordisk, Eli Lilly, Merck Serono, F. Hoffmann-La Roche, Ferring Pharmaceuticals, Ipsen and LG Life Sciences, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers’ production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Long-Acting Growth Hormone(LAGH) manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Long-Acting Growth Hormone(LAGH) market. Further, it explains the major drivers and regional dynamics of the global Long-Acting Growth Hormone(LAGH) market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
GeneScience Pharmaceuticals
Pfizer
Novo Nordisk
Eli Lilly
Merck Serono
F. Hoffmann-La Roche
Ferring Pharmaceuticals
Ipsen
LG Life Sciences
Sandoz International
Anhui Anke Biotechnology
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on sales, price, and value for the period 2017-2028.
Long-Acting Growth Hormone(LAGH) Segment by Type
Powder
Solvent
Long-Acting Growth Hormone(LAGH) Segment by Application
Growth Hormone Deficiency (GHD)
Turner Syndrome
Chronic Renal Insufficiency
Prader Willi Syndrome
Small for Gestational Age(SGA)
SHOX Deficiency
Others
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Long-Acting Growth Hormone(LAGH) market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Long-Acting Growth Hormone(LAGH), sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Long-Acting Growth Hormone(LAGH), also provides the sales of main regions and countries. Highlights of the upcoming market potential for Long-Acting Growth Hormone(LAGH), and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Long-Acting Growth Hormone(LAGH) sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Long-Acting Growth Hormone(LAGH) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Long-Acting Growth Hormone(LAGH) sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including GeneScience Pharmaceuticals, Pfizer, Novo Nordisk, Eli Lilly, Merck Serono, F. Hoffmann-La Roche, Ferring Pharmaceuticals, Ipsen and LG Life Sciences, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Long-Acting Growth Hormone(LAGH) in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Long-Acting Growth Hormone(LAGH) manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country, sales and revenue for each segment.
Chapter 9: Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Long-Acting Growth Hormone(LAGH) sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
1 Study Coverage
1.1 Long-Acting Growth Hormone(LAGH) Product Introduction
1.2 Market by Type
1.2.1 Global Long-Acting Growth Hormone(LAGH) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Powder
1.2.3 Solvent
1.3 Market by Application
1.3.1 Global Long-Acting Growth Hormone(LAGH) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Growth Hormone Deficiency (GHD)
1.3.3 Turner Syndrome
1.3.4 Chronic Renal Insufficiency
1.3.5 Prader Willi Syndrome
1.3.6 Small for Gestational Age(SGA)
1.3.7 SHOX Deficiency
1.3.8 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Long-Acting Growth Hormone(LAGH) Sales Estimates and Forecasts 2017-2028
2.2 Global Long-Acting Growth Hormone(LAGH) Revenue Estimates and Forecasts 2017-2028
2.3 Global Long-Acting Growth Hormone(LAGH) Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Long-Acting Growth Hormone(LAGH) Sales by Region
2.4.1 Global Long-Acting Growth Hormone(LAGH) Sales by Region (2017-2022)
2.4.2 Global Sales Long-Acting Growth Hormone(LAGH) by Region (2023-2028)
2.5 Global Long-Acting Growth Hormone(LAGH) Revenue by Region
2.5.1 Global Long-Acting Growth Hormone(LAGH) Revenue by Region (2017-2022)
2.5.2 Global Long-Acting Growth Hormone(LAGH) Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Long-Acting Growth Hormone(LAGH) Sales by Manufacturers
3.1.1 Global Top Long-Acting Growth Hormone(LAGH) Manufacturers by Sales (2017-2022)
3.1.2 Global Long-Acting Growth Hormone(LAGH) Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Long-Acting Growth Hormone(LAGH) in 2021
3.2 Global Long-Acting Growth Hormone(LAGH) Revenue by Manufacturers
3.2.1 Global Long-Acting Growth Hormone(LAGH) Revenue by Manufacturers (2017-2022)
3.2.2 Global Long-Acting Growth Hormone(LAGH) Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Long-Acting Growth Hormone(LAGH) Revenue in 2021
3.3 Global Long-Acting Growth Hormone(LAGH) Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Long-Acting Growth Hormone(LAGH) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Long-Acting Growth Hormone(LAGH) Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Long-Acting Growth Hormone(LAGH) Sales by Type
4.1.1 Global Long-Acting Growth Hormone(LAGH) Historical Sales by Type (2017-2022)
4.1.2 Global Long-Acting Growth Hormone(LAGH) Forecasted Sales by Type (2023-2028)
4.1.3 Global Long-Acting Growth Hormone(LAGH) Sales Market Share by Type (2017-2028)
4.2 Global Long-Acting Growth Hormone(LAGH) Revenue by Type
4.2.1 Global Long-Acting Growth Hormone(LAGH) Historical Revenue by Type (2017-2022)
4.2.2 Global Long-Acting Growth Hormone(LAGH) Forecasted Revenue by Type (2023-2028)
4.2.3 Global Long-Acting Growth Hormone(LAGH) Revenue Market Share by Type (2017-2028)
4.3 Global Long-Acting Growth Hormone(LAGH) Price by Type
4.3.1 Global Long-Acting Growth Hormone(LAGH) Price by Type (2017-2022)
4.3.2 Global Long-Acting Growth Hormone(LAGH) Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Long-Acting Growth Hormone(LAGH) Sales by Application
5.1.1 Global Long-Acting Growth Hormone(LAGH) Historical Sales by Application (2017-2022)
5.1.2 Global Long-Acting Growth Hormone(LAGH) Forecasted Sales by Application (2023-2028)
5.1.3 Global Long-Acting Growth Hormone(LAGH) Sales Market Share by Application (2017-2028)
5.2 Global Long-Acting Growth Hormone(LAGH) Revenue by Application
5.2.1 Global Long-Acting Growth Hormone(LAGH) Historical Revenue by Application (2017-2022)
5.2.2 Global Long-Acting Growth Hormone(LAGH) Forecasted Revenue by Application (2023-2028)
5.2.3 Global Long-Acting Growth Hormone(LAGH) Revenue Market Share by Application (2017-2028)
5.3 Global Long-Acting Growth Hormone(LAGH) Price by Application
5.3.1 Global Long-Acting Growth Hormone(LAGH) Price by Application (2017-2022)
5.3.2 Global Long-Acting Growth Hormone(LAGH) Price Forecast by Application (2023-2028)
6 North America
6.1 North America Long-Acting Growth Hormone(LAGH) Market Size by Type
6.1.1 North America Long-Acting Growth Hormone(LAGH) Sales by Type (2017-2028)
6.1.2 North America Long-Acting Growth Hormone(LAGH) Revenue by Type (2017-2028)
6.2 North America Long-Acting Growth Hormone(LAGH) Market Size by Application
6.2.1 North America Long-Acting Growth Hormone(LAGH) Sales by Application (2017-2028)
6.2.2 North America Long-Acting Growth Hormone(LAGH) Revenue by Application (2017-2028)
6.3 North America Long-Acting Growth Hormone(LAGH) Market Size by Country
6.3.1 North America Long-Acting Growth Hormone(LAGH) Sales by Country (2017-2028)
6.3.2 North America Long-Acting Growth Hormone(LAGH) Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Long-Acting Growth Hormone(LAGH) Market Size by Type
7.1.1 Europe Long-Acting Growth Hormone(LAGH) Sales by Type (2017-2028)
7.1.2 Europe Long-Acting Growth Hormone(LAGH) Revenue by Type (2017-2028)
7.2 Europe Long-Acting Growth Hormone(LAGH) Market Size by Application
7.2.1 Europe Long-Acting Growth Hormone(LAGH) Sales by Application (2017-2028)
7.2.2 Europe Long-Acting Growth Hormone(LAGH) Revenue by Application (2017-2028)
7.3 Europe Long-Acting Growth Hormone(LAGH) Market Size by Country
7.3.1 Europe Long-Acting Growth Hormone(LAGH) Sales by Country (2017-2028)
7.3.2 Europe Long-Acting Growth Hormone(LAGH) Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Long-Acting Growth Hormone(LAGH) Market Size by Type
8.1.1 Asia Pacific Long-Acting Growth Hormone(LAGH) Sales by Type (2017-2028)
8.1.2 Asia Pacific Long-Acting Growth Hormone(LAGH) Revenue by Type (2017-2028)
8.2 Asia Pacific Long-Acting Growth Hormone(LAGH) Market Size by Application
8.2.1 Asia Pacific Long-Acting Growth Hormone(LAGH) Sales by Application (2017-2028)
8.2.2 Asia Pacific Long-Acting Growth Hormone(LAGH) Revenue by Application (2017-2028)
8.3 Asia Pacific Long-Acting Growth Hormone(LAGH) Market Size by Region
8.3.1 Asia Pacific Long-Acting Growth Hormone(LAGH) Sales by Region (2017-2028)
8.3.2 Asia Pacific Long-Acting Growth Hormone(LAGH) Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Long-Acting Growth Hormone(LAGH) Market Size by Type
9.1.1 Latin America Long-Acting Growth Hormone(LAGH) Sales by Type (2017-2028)
9.1.2 Latin America Long-Acting Growth Hormone(LAGH) Revenue by Type (2017-2028)
9.2 Latin America Long-Acting Growth Hormone(LAGH) Market Size by Application
9.2.1 Latin America Long-Acting Growth Hormone(LAGH) Sales by Application (2017-2028)
9.2.2 Latin America Long-Acting Growth Hormone(LAGH) Revenue by Application (2017-2028)
9.3 Latin America Long-Acting Growth Hormone(LAGH) Market Size by Country
9.3.1 Latin America Long-Acting Growth Hormone(LAGH) Sales by Country (2017-2028)
9.3.2 Latin America Long-Acting Growth Hormone(LAGH) Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Long-Acting Growth Hormone(LAGH) Market Size by Type
10.1.1 Middle East and Africa Long-Acting Growth Hormone(LAGH) Sales by Type (2017-2028)
10.1.2 Middle East and Africa Long-Acting Growth Hormone(LAGH) Revenue by Type (2017-2028)
10.2 Middle East and Africa Long-Acting Growth Hormone(LAGH) Market Size by Application
10.2.1 Middle East and Africa Long-Acting Growth Hormone(LAGH) Sales by Application (2017-2028)
10.2.2 Middle East and Africa Long-Acting Growth Hormone(LAGH) Revenue by Application (2017-2028)
10.3 Middle East and Africa Long-Acting Growth Hormone(LAGH) Market Size by Country
10.3.1 Middle East and Africa Long-Acting Growth Hormone(LAGH) Sales by Country (2017-2028)
10.3.2 Middle East and Africa Long-Acting Growth Hormone(LAGH) Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 GeneScience Pharmaceuticals
11.1.1 GeneScience Pharmaceuticals Corporation Information
11.1.2 GeneScience Pharmaceuticals Overview
11.1.3 GeneScience Pharmaceuticals Long-Acting Growth Hormone(LAGH) Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 GeneScience Pharmaceuticals Long-Acting Growth Hormone(LAGH) Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 GeneScience Pharmaceuticals Recent Developments
11.2 Pfizer
11.2.1 Pfizer Corporation Information
11.2.2 Pfizer Overview
11.2.3 Pfizer Long-Acting Growth Hormone(LAGH) Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Pfizer Long-Acting Growth Hormone(LAGH) Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Pfizer Recent Developments
11.3 Novo Nordisk
11.3.1 Novo Nordisk Corporation Information
11.3.2 Novo Nordisk Overview
11.3.3 Novo Nordisk Long-Acting Growth Hormone(LAGH) Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Novo Nordisk Long-Acting Growth Hormone(LAGH) Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Novo Nordisk Recent Developments
11.4 Eli Lilly
11.4.1 Eli Lilly Corporation Information
11.4.2 Eli Lilly Overview
11.4.3 Eli Lilly Long-Acting Growth Hormone(LAGH) Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Eli Lilly Long-Acting Growth Hormone(LAGH) Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Eli Lilly Recent Developments
11.5 Merck Serono
11.5.1 Merck Serono Corporation Information
11.5.2 Merck Serono Overview
11.5.3 Merck Serono Long-Acting Growth Hormone(LAGH) Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Merck Serono Long-Acting Growth Hormone(LAGH) Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Merck Serono Recent Developments
11.6 F. Hoffmann-La Roche
11.6.1 F. Hoffmann-La Roche Corporation Information
11.6.2 F. Hoffmann-La Roche Overview
11.6.3 F. Hoffmann-La Roche Long-Acting Growth Hormone(LAGH) Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 F. Hoffmann-La Roche Long-Acting Growth Hormone(LAGH) Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 F. Hoffmann-La Roche Recent Developments
11.7 Ferring Pharmaceuticals
11.7.1 Ferring Pharmaceuticals Corporation Information
11.7.2 Ferring Pharmaceuticals Overview
11.7.3 Ferring Pharmaceuticals Long-Acting Growth Hormone(LAGH) Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Ferring Pharmaceuticals Long-Acting Growth Hormone(LAGH) Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Ferring Pharmaceuticals Recent Developments
11.8 Ipsen
11.8.1 Ipsen Corporation Information
11.8.2 Ipsen Overview
11.8.3 Ipsen Long-Acting Growth Hormone(LAGH) Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Ipsen Long-Acting Growth Hormone(LAGH) Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Ipsen Recent Developments
11.9 LG Life Sciences
11.9.1 LG Life Sciences Corporation Information
11.9.2 LG Life Sciences Overview
11.9.3 LG Life Sciences Long-Acting Growth Hormone(LAGH) Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 LG Life Sciences Long-Acting Growth Hormone(LAGH) Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 LG Life Sciences Recent Developments
11.10 Sandoz International
11.10.1 Sandoz International Corporation Information
11.10.2 Sandoz International Overview
11.10.3 Sandoz International Long-Acting Growth Hormone(LAGH) Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Sandoz International Long-Acting Growth Hormone(LAGH) Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Sandoz International Recent Developments
11.11 Anhui Anke Biotechnology
11.11.1 Anhui Anke Biotechnology Corporation Information
11.11.2 Anhui Anke Biotechnology Overview
11.11.3 Anhui Anke Biotechnology Long-Acting Growth Hormone(LAGH) Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Anhui Anke Biotechnology Long-Acting Growth Hormone(LAGH) Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Anhui Anke Biotechnology Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Long-Acting Growth Hormone(LAGH) Industry Chain Analysis
12.2 Long-Acting Growth Hormone(LAGH) Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Long-Acting Growth Hormone(LAGH) Production Mode & Process
12.4 Long-Acting Growth Hormone(LAGH) Sales and Marketing
12.4.1 Long-Acting Growth Hormone(LAGH) Sales Channels
12.4.2 Long-Acting Growth Hormone(LAGH) Distributors
12.5 Long-Acting Growth Hormone(LAGH) Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Long-Acting Growth Hormone(LAGH) Industry Trends
13.2 Long-Acting Growth Hormone(LAGH) Market Drivers
13.3 Long-Acting Growth Hormone(LAGH) Market Challenges
13.4 Long-Acting Growth Hormone(LAGH) Market Restraints
14 Key Findings in The Global Long-Acting Growth Hormone(LAGH) Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer